版本:
中国

BRIEF-GSK reports positive results with single-dose tafenoquine in malaria

June 12 GlaxoSmithKline Plc

* GSK and MMV announce positive headline Phase III results showing single-dose tafenoquine reduces risk of relapse in patients with Plasmodium vivax malaria Further company coverage: (Reporting by UK bureau)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐